This phenomenon may be associated with greater cytotoxic NK cell infiltration into the tumor in the PD-1+SMI group than in the remaining groups, indicating that the PD-1 inhibitor combined with SMI may enhance the antitumor efficacy via NK cell-mediated tumor cell apoptosis. This evidence concerns the gene PDCD1 and neoplasm.